PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
Jiang TY, Pan YF, Wan ZH, Lin YK, Zhu B, Yuan ZG, Ma YH, Shi YY, Zeng TM, Dong LW, Tan YX, Wang HY.
Jiang TY, et al. Among authors: ma yh.
Sci Transl Med. 2020 Sep 23;12(562):eaay0152. doi: 10.1126/scitranslmed.aay0152.
Sci Transl Med. 2020.
PMID: 32967970